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We report the magnetic resonance imaging and proton magnetic resonance spectroscopic findings (1HMRS) in a patient with
a focal cortical dysgenesis in the right superior frontal gyrus during intermittent frontal status epilepticus (IFSE) with simple
partial seizures, and after she had become seizure free.
During the status epilepticus, demonstrated by simultaneous behavioural and electroencephalographic telemetric long-term
monitoring with scalp electrodes and ictal SPECT, we performed a single voxel spectroscopy of the dysgenic cortex. The
1HMRS was repeated after 20 days when the patient’s seizures were controlled.
The N-acetyl-aspartate concentration in the focal dysgenic cortex was decreased in the interictal state but more during IFSE.
The creatine/phosphocreatine concentration was normal in both instances. There was a clear lactate signal during IFSE, which
was no longer visible in the interictal state.
To our knowledge this is the first report of a 1HMRS study of a focal cortical dysgenesis during an intermittent status
epilepticus. We interpret the observed changes as signs of histopathological changes inherent to a cortical malformation and of
an impaired energy metabolism due to the partial status epilepticus.
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INTRODUCTION
Cerebral cortical malformations consist of a group
of heterogeneous disorders of cortical development
and organization, and often are associated with diffi-
cult to treat epileptic seizures and mental retardation.
Magnetic resonance imaging (MRI) allows the detec-
tion of such abnormalities in an increasing number of
patients previously thought to suffer from cryptogenic
epilepsy. In contrast to other structural lesions such
as tumours, which are thought to be mainly epilepto-
genic by their effect on the surrounding cortex, cortical
malformations show signs of intrinsic epileptogenic-
ity1. The mechanisms of this epileptogenicity are un-
known. Metabolic investigations of these malforma-
tions in vivo during interictal and ictal state with mag-
netic resonance spectroscopy (1HMRS) may help to
elucidate some of these mechanisms. We report the
findings in a patient with a right frontal focal dys-
genic cortex during an intermittent simple partial sta-
tus epilepticus and after she had become seizure free,
i.e. in the interictal state.
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CASE REPORT
At the time of investigation our patient, a left-handed
woman with medically intractable partial seizures, was
20 year old. She was born as the second of five sib-
lings; pregnancy and delivery had been uneventful.
There was no other case of epilepsy in the family. The
seizures started at the age of 8 years and showed a
stereotypical semiology. Initial symptoms were nausea
and dizziness. They were followed by a tingling sensa-
tion in the epigastrium spreading over the whole body,
and an urge to move with accompanying hyperventi-
lation. Sometimes these symptoms were followed by
crying and weeping. The patient had been treated with
phenobarbital, barbexaclone, carbamazepine, oxcar-
bazepine, clonazepam, valproate, lamotrigine and vi-
gabatrin in monotherapy and in various combinations
but continued to have 4–8 seizures monthly, mostly out
of sleep. Repeated interictal scalp EEGs, done in other
hospitals, had shown isolated spikes in the right frontal
region. Several CT-scans and a routine T1-weighted
MRI examination were reported to be normal.
The patient stopped taking her medication with-
out consulting her treating neurologist after a so-
called spiritual healer had told her that antiepilep-
tic drugs are harmful. Three days later she experi-
enced her habitual seizures recurring with a frequency
of one seizure every 10 minutes and was admitted
to our hospital. Despite treatment with a continu-
ous midazolam infusion (max 8 mg per hour), com-
plemented by a combination of valproate and lam-
otrigine per os, the intermittent partial status epilep-
ticus continued for 8 days. A MRI was performed
on the 4th day after admission and showed an in-
distinct grey matter–white matter junction along the
right superior frontal sulcus characteristic of a focal
cortical dysgenesis; probably a focal polymicrogyria
(Fig. 1). An ictal SPECT revealed a hyperperfusion in
the same region (Fig. 2). An electroencephalographic
long-term monitoring for 24 hours was done on the
5th day with standard 10/20 scalp electrodes and ev-
ery 4 to 5 minutes showed a seizure discharge with
the build-up of a rhythmic slowing with a maximum
over the right fronto-central region associated with
typical nausea and dizziness without loss or impair-
ment of consciousness. At this time the seizures no
longer progressed to crying and weeping. The first
1HMRS was done on the 6th day after admission.
At this time the patient still experienced nausea and
dizziness without crying and weeping at least every
15 to 20 minutes. Because we had no MR-suitable
EEG equipment, we were not able to record the EEG
during the spectroscopy, but the patient reported a
simple partial seizure immediately before the mea-
surement and another during the measurement. The
1HMRS was repeated 4 weeks after the first exami-
nation. At this time the patient had been seizure free
for 23 days.
MATERIALS AND METHODS
Proton magnetic resonance imaging and
spectroscopy
The imaging studies were done on a GE Signa
1.5 Tesla whole-body system with a standard imaging
head coil using a T2-weighted fast spin echo (FSE)
sequence (repetition time (TR)/echo time (TE)=
3500/105 milliseconds). The spectroscopy studies
were performed on a Philips Gyroscan ACS-NT 1.5
Tesla whole-body system equipped with a send–
receive proton head coil (Philips Medical Systems,
Best, The Netherlands). A T2-weighted Scout-MRI
was acquired and a 20 × 10 × 14 mm3 volume
of interest (VOI) covering the lesion was placed
in the right frontal lobe. Localization was achieved
with a PRESS sequence consisting of a 90◦ excita-
tion pulse and two 180◦ refocusing pulses in com-
bination with slice-selective spatial gradients in all
three spatial directions (TE= 136 milliseconds, rep-
etition time TR= 6000 milliseconds, 2048 samples,
2000 Hz sampling frequency, 64 averages). The wa-
ter signal was suppressed by an optimized double
CHESS sequence. In order to quantify the in vivo ac-
quired metabolite signals, the measurement was re-
peated on a head-shaped phantom using the same ac-
quisition parameters. The phantom was filled with a
solution containing 41 mmol KCl and 33.33 mmol
N-acetylaspartate (NAA) doped with 100 mg l−1
NiCl2 · 6H2O. Signal processing was performed on a
DEC Alpha workstation using processing software de-
veloped at our site based on DI 3000. The time domain
signals were multiplied with an exponential function
resulting in a line broadening of 1.5 Hz. After Fourier
transformation a phase correction of zero order and
a baseline correction were performed. The frequency
signals of NAA, creatine and phosphocreatine (Cr) and
choline containing compounds (Cho) were fitted by a
least square fitting procedure assuming Lorentzian line
shapes starting with an interactively created parameter
list which contains peak amplitude and frequency es-
timates. From the amplitudes the absolute metabolite
concentrations were calculated as described2. Two ad-
ditional spectra using the same parameters but a dif-
ferent TE, i.e. TE= 30 and 272 milliseconds, were
acquired. For these spectra relative metabolite ratios
were determined. Four weeks later, i.e. at a time
when the patient was seizure free, the measurements
were repeated using the same acquisition parameters
and quantification methods. In the measurement with
TE= 136 milliseconds a lactate signal was no longer
visible. It had not been possible to perform contralat-
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Fig. 1: (a) Sagittal and (b) axial T2-weighted FSE (fast spin echo) (TR/TE=3500/105 milliseconds) MR images showing a nodular
mass, hyperintense to grey matter in the right frontal region. The VOI-localization used in the spectroscopic measurements is
indicated by squares. Please note that displayed images are not those obtained for the spectroscopic measurement.
eral measurements the first time because the patient
could not tolerate staying longer than 60 minutes in
the scanner. Thus we did without contralateral mea-
surements the second time.
RESULTS
The MR images show a nodular mass, hyperin-
tense to grey matter in the right frontal region ex-
tending around the anterior portion of the superior
frontal sulcus characteristic for a focal dysgenic cor-
tex (cf. Fig. 1). From the aspect in the MRI, the le-
sion is probably a focal polymicrogyria. Table 1 dis-
plays the absolute concentrations and the peak area ra-
tios of the different metabolites during the intermittent
frontal status epilepticus (IFSE) and interictal phase.
Figure 3 displays the spectra obtained in the IFSE and
interictal state. In a group of 28 healthy volunteers
(aged 18–40 years) the mean concentration for NAA
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Fig. 2: (a) Ictal SPECT with 500 Mbq 99 m Tc HM-PAO showing a hyperperfusion in the area of the dysgenic cortex. Tracer
injection at the beginning of rhythmic frontal seizure discharges. (b) Interictal SPECT with 500 Mbq 99 m Tc HM-PAO. The area of
hyperperfusion is no longer visible.
in the frontal grey matter was 14.1 ± 0.91 mmol l−1
(95% confidence interval 12.3–15.9 mmol l−1). For
Cr it was 8.6 ± 1.23 mmol l−1 (95% confidence in-
terval 5.01–12.2) and for Cho 2.5 ± 0.37 mmol l−1
(95% confidence interval 1.8–3.2). For repetitive mea-
surements in healthy volunteers the standard deviation
in percent (SD%) was 10% for NAA and 20% for
Cr and Cho2. Compared with values of normal con-
trols, the NAA signal in the focal dysgenic cortex was
clearly decreased during IFSE and in interictal state,
but more during IFSE. The Cr concentrations of our
patient were in the normal range in both instances. The
Cho concentration was increased in both instances but
more so during IFSE2. The resolution of the Cr and
Cho peaks in both interictal measurements was poor
thus we have to interpret the IFSE/interictal changes
of these metabolites cautiously. A lactate (Lac) signal
was clearly visible in the ictal TE= 136 and 272 spec-
tra but no longer in the interictal TE= 136 spectrum.
The integrated peak area for the Glnx (metabolites in
the spectral region between 2.1–2.4 ppm, i.e. GABA,
glutamine and glutamate) was also higher during IFSE
than in the interictal state. However, the broad peak at
0.9 ppm in the ictal TE= 30 spectrum indicates in-
creased contributions from macromolecules thus the
IFSE elevation of the Glnx region cannot solely be at-
tributed to GABA, glutamate and glutamine. For the
TE= 30 milliseconds measurement the NAA/Cr ra-
tio was not determined because the NAA-peak was
not separated from the Glnx (glutamine, glutamate,
GABA) peak in the ictal state spectrum and there were
macromolecule contributions in these region in ictal
and interictal spectrum. The NAA/Cr ratio in the ic-
tal TE= 136 and 272 milliseconds were identical, i.e.
0.4. There was no significant change in the T2 relax-
ation time constant between the IFSE and interictal
measurement excluding a localized ictal oedema as an
explanation for the metabolic changes.
Table 1: Metabolites in mmol l−1 and in ratio to creatine
during status epilepticus and in interictal state.
TE 136 TE 30 TE 272
mmol l−1 Ratio Ratio
STATUS
NAA 5.9 (↓)
Cr 12.9
Cho 5.5 (↑)
Glnx/Cr 2.3
Lac/Cr 0.4 0.3 (↑)
INTERICTAL
NAA 6.7 (↓)
Cr 10.4
Cho 3.3
Glnx/Cr 1.3
Lac/Cr none nd
NAA, N-acetyl-aspartate; Cr, creatine and phosphocreatine; Cho,
choline containing compounds; Glnx, glutamine, glutamate,
GABA; Lac, lactate. TE, echo time in milliseconds; nd, not done;
none, signal not above noise; bold, pathological values.
DISCUSSION
The most prominent finding in the interictal state
was a reduced NAA-signal in the region of the cor-
tical dysplasia. NAA is conventionally considered to
be a marker of functional neurons in the adult brain
and a reduction of NAA is usually interpreted as re-
duced neuronal density and/or neuronal dysfunction.
Because the seizures were well controlled at the time
of the second examination and presently occur only in-
frequently, the patient has not so far undergone surgery
and the suspected type of focal cortical malforma-
tion has not been confirmed histopathologically. Be-
cause the patient was admitted for the first time to
our hospital during the IFSE, we have no previous
spectroscopic examination and are therefore not able
to distinguish between neuronal cell loss due to the
neurotoxic effects of the IFSE or due to histopatho-
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Fig. 3: Spectra obtained during the intermittent frontal partial status epilepticus and the interictal state. The firs three spectra
represent ictal/peri-ictal, the last two interictal spectra. For acquisition parameters cf. text. In the interictal spectra the peak
representing lactate (Lac) is no longer visible and the peak representing N-acetyl-aspartate (NAA) is increased compared to the
intermittent status epilepticus. TE, echo time; Cr, creatine and phosphocreatine; Cho, choline containing compounds; Glnx,
glutamine, glutamate, GABA.
logical characteristics inherent to the type of corti-
cal malformation. There are three studies reporting
larger series of interictal spectroscopic findings in cor-
tical developmental malformations3–5. All found de-
creased NAA/Cr ratios in focal cortical dysplasias
but differed in their findings in other types of cor-
tical malformations. For example, in polymicrogyric
and heterotopic lesions the NAA/Cr ratios varied be-
tween normal or slightly abnormal3, 4 to clearly abnor-
mal5. As in our patient the classification of the type
of malformation relied in most instances on MRI fea-
tures alone and was not histopathologically confirmed.
However, cortical developmental malformations may
histopathologically differ despite identical MRI fea-
tures or macroscopic aspect, for example, polymicr-
ogyric lesions may have a two- or a four-layered cor-
tex6, and such structural differences may well explain
the divergent findings of the three studies. Therefore,
without larger studies correlating spectroscopic find-
ings rigorously with histopathological findings spec-
troscopic measurements may not be helpful for the
differentiation of different histopathological types of
cortical dysgenesis.
The reduction of the NAA-signal in the region of
the focal cortical dysgenesis was more marked dur-
ing the IFSE. The known biochemical facts about
NAA and epileptic discharges would lead one to
expect no change or a decrease of the NAA con-
centration after a seizure. In kindled rats seizures
decrease the activity of the enzyme N-acetylated-
alpha-linked acidic dipeptidase which hydrolyses N-
acetyl-aspartylglutamate (NAAG) into glutamate and
NAA, inducing an increase of NAAG and a de-
crease of NAA7. Another study found a signif-
icant decrease of both—NAA and NAAG—after
pentamethylenetetrazol-induced seizures8. In addition
to these findings there is evidence that the synthesis
of NAA in the mitochondria is an oxygen and/or ATP
demanding process9. While spectroscopic measure-
ments showed that total ATP levels remain stable dur-
ing prolonged seizures under normoxic and normoten-
sive conditions10, 11, there is evidence that mitochon-
drial ATP levels may significantly decrease12. There-
fore, NAA reductions after a seizure do not necessarily
reflect an irreversible neuronal loss but can also be a
marker of a reversible neuronal dysfunction. The find-
ings of spectroscopic measurements in animal models
immediately after seizures are divergent. While Petroff
and co-workers10 found only small or no changes of
NAA during bicuculline-induced seizures in rabbits,
Najm and co-workers found significant increases of
NAA during the ictal phase in kainic acid induced
seizures and in the kindling model in rats13–15.
At the time of the first 1HMRS examination our
patient had experienced seizures over several days
with only short seizure-free intervals. Thus, even if we
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hypothesize that she might have no change or an ini-
tial increase of the NAA concentration during the first
seizures, after several days with repetitive seizures a
cellular energy impairment and consequently a NAA
decrease had to be expected. Furthermore, pathologi-
cal neuronal cells in cortical malformations may not
have the same enzymatic and metabolic capacities
as normal neuronal cells and therefore be even more
at risk for a metabolic impairment during repetitive
seizures16. The slight increase of NAA in the interictal
state compared to IFSE supports the theory of a func-
tional, reversible component of the NAA reduction
due to seizure-induced metabolic disturbances.
Another factor supporting the theory of an impaired
energy metabolism during IFSE is the Lac-signal in
the ictal spectra which is no longer visible in the inter-
ictal spectra. An ictal and post-ictal increase of Lac,
not only in the epileptogenic focus but also in the
projection areas, was also observed in above men-
tioned animal studies dependent on the duration and
severity of seizures10, 13–15. The mechanisms for the
Lac accumulation after seizures are unknown. It has
been assumed to be the result of a mismatch between
glycolysis and oxidative metabolism or a temporary
dys-equilibrium between lactate production and clear-
ance17, 18. Interestingly, the Lac increase could not be
demonstrated consistently in ictal studies in humans.
While Fazekas and co-workers failed to observe a Lac-
signal in a patient with an intermittent focal status
epilepticus over several days19, the ictal spectra of the
patient of Lazeyras and co-workers also showed a Lac-
signal20. This group also found an elevated Cho-signal
during the ictal state as we did. Because phospholipid
synthesis is an energy demanding process depending
on mitochondrial metabolism, the enhanced visibil-
ity of Cho indicating an accumulation of phospholipid
breakdown products further supports the theory of an
impaired energy metabolism.
In conclusion the spectroscopic examination during
the intermittent frontal partial status epilepticus shows
signs of an impaired energy metabolism in the region
of the focal cortical dysgenesis. In the interictal state
we found signs of a reduced neuronal density probably
mostly reflecting the pathological histology of a focal
cortical dysgenesis.
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